Johnson & Johnson to acquire Momenta Pharmaceuticals for $6.5B By: Philadelphia Business Journal via Business Journals August 19, 2020 at 12:56 PM EDT The real value for Johnson & Johnson is Momenta’s pipeline, led by a potential drug for anemia. Read More >>